Analytical Development and Qualification Services for LBPs at Creative Biolabs
New York, USA – July 7, 2022 – Live biotherapeutic products (LBPs) are composed of microorganisms that are either the same as or similar to microorganisms found naturally in the human body. LBPs are expected to treat an extensive range of severe diseases, including gastrointestinal disorders, metabolic diseases, and cancers. Therefore, LBPs reserved a huge potential market. But before marketing, LBPs must undergo analytical development and qualification to further prove safety and efficacy.
With rich experience and knowledge, Creative Biolabs provides analytical development and qualification services, including but not limited to:
• Microbial Isolation and Screening
• Functional Screening and Mechanism of Action
• Dissolution Testing and Drug Release Profiling
• QC Analytical Testing
Microbial Isolation and Screening Services for Live Biotherapeutic Products
A potentially excellent strain is the key to LBP development, with its process covering sample treatment, analysis of microorganisms, optimization of medium and culture conditions, to the acquisition of pure culture.
Creative Biolabs has developed the microbial isolation and screening platform that can collect more microbial species and acquire more “difficult to culture” microorganisms, thereby obtaining extensive unique microbial resources.
Functional Screening and Mechanism of Action for Live Biotherapeutic Products
LBPs work by modulating the microbiota of the host and mediating sorts of signals, thus triggering a variety of physiological pathways. The molecular mechanisms of interaction between the gut commensals and host cells result in a variety of effects on the host.
Creative Biolabs can help speed up LBP project development by providing a novel and promising strain along with functional screening and mechanism of action services. Creative Biolabs is dedicated to enabling microbes and probiotics to reveal novel therapeutic functions for drug development programs.
Dissolution Testing and Drug Release Profiling for Live Biotherapeutic Products
In order to assist with dosage optimization, dissolution testing is a standardized method for measuring the rate of drug release in a given dosage form.
Creative Biolabs has extensive experience designing optimal dissolution procedures and considers all parameters, including API, formulation, and analytical methods. With Creative Biolabs’ services, LBP drug development can be accelerated.
QC Analytical Testing for Live Biotherapeutic Products
QC analysis is essential for demonstrating if a drug product is suitable for specific purposes. QC analytical testing laboratories at Creative Biolabs are equipped with state-of-the-art analytical equipment and testing facilities. Thus, Creative Biolabs is able to offer full-scale QC analytical testing that covers common validation for the characteristics of LBPs, including moisture analysis, colony morphology, cell morphology, appearance, microbial limits testing, and bioburden determination.
Explore more LBP-related services from Creative Biolabs at https://live-biotherapeutic.creative-biolabs.com.
About Creative Biolabs
Combining expertise in biochemistry, molecular biology, immunology, and cell biology, Creative Biolabs is capable of delivering a wide range of services for the analytical development, functional characterization, and validation of LBP.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://live-biotherapeutic.creative-biolabs.com
